
Reset all filters
01 2Complera/Eviplera
02 2Stribild
03 1Truvada
Main Therapeutic Indication : Infectious Diseases
Currency : USD
2022 Revenue in Millions : 127
2021 Revenue in Millions : 189
Growth (%) : -33
Main Therapeutic Indication : Infectious Diseases
Currency : USD
2022 Revenue in Millions : 200
2021 Revenue in Millions : 258
Growth (%) : -22
Main Therapeutic Indication : Infectious Diseases
Currency : USD
2023 Revenue in Millions : 129
2022 Revenue in Millions : 200
Growth (%) : -36
Main Therapeutic Indication : Infectious Diseases
Currency : USD
2023 Revenue in Millions : 101
2022 Revenue in Millions : 127
Growth (%) : -20
Emtricitabine, Tenofovir Disoproxil Fumarate
Main Therapeutic Indication : Infectious Diseases (HIV, Hepatitis...
Currency : USD
2018 Revenue in Millions : 2,997
2017 Revenue in Millions : 3,134
Growth (%) : -4%